Prescribing Vitamin D3 When Not Listed in Your EMR
If vitamin D3 (cholecalciferol) is not available in your EMR formulary, prescribe vitamin D2 (ergocalciferol) instead, which is widely available as a prescription medication in the 50,000 IU capsule formulation. 1
Alternative Prescribing Options
First-Line Alternative: Ergocalciferol (Vitamin D2)
- Available as prescription-strength 50,000 IU capsules under brand names Calciferol™ or Drisdol™ 1
- For prevention: 50,000 IU once monthly achieves approximately 2,000 IU/day equivalent 1
- For treatment of deficiency: 50,000 IU weekly for 8-12 weeks, then monthly maintenance 1, 2, 3
If Cholecalciferol (D3) is Preferred
While guidelines suggest ergocalciferol may be safer in certain contexts 1, cholecalciferol is actually preferred when available because:
- Better sustained serum levels with intermittent dosing compared to D2 4
- More reliable 25(OH)D assay measurement (D2 can cause spuriously low readings on some assays) 2, 4
- Similar efficacy with daily dosing 4
Cholecalciferol is available over-the-counter in lower doses:
- 400 IU, 1,000 IU, 2,000 IU, 5,000 IU, and 10,000 IU formulations
- You can write a prescription for "cholecalciferol 50,000 IU capsules weekly" even if not in your EMR—pharmacies stock this 5
Practical Prescribing Strategies
For Maintenance/Prevention (25[OH]D >20 ng/mL)
- Ergocalciferol 50,000 IU once monthly 1
- OR instruct patient to purchase OTC cholecalciferol 2,000 IU daily 2
- Target: maintain 25(OH)D ≥30 ng/mL for optimal bone health 2, 3
For Treatment of Deficiency (25[OH]D <20 ng/mL)
Ergocalciferol regimen:
- 50,000 IU weekly for 8 weeks 2, 3, 4
- Recheck 25(OH)D level 3 months after starting 4
- Then maintenance: 50,000 IU monthly or 1,000-2,000 IU daily 2
Alternative cholecalciferol regimen (if prescribing OTC):
For Severe Deficiency (25[OH]D <10 ng/mL)
- Ergocalciferol 50,000 IU weekly for 12 weeks, then monthly 1
- Higher doses (up to 7,000 IU daily or 30,000-50,000 IU weekly) are safe and effective in high-risk populations 6
Important Clinical Considerations
When D2 vs D3 Matters
- Daily dosing: D2 and D3 are equivalent 4
- Intermittent dosing (weekly/monthly): D3 maintains levels longer and is preferred 4
- Assay concerns: If patient receives high-dose D2, ensure lab uses LC-MS/MS assay that measures both 25(OH)D2 and 25(OH)D3 2, 4
Special Populations Requiring Higher Doses
Consider higher maintenance doses (up to 7,000 IU daily or 50,000 IU weekly) for 6:
- Obesity (vitamin D is sequestered in adipose tissue)
- Malabsorption syndromes (celiac, IBD, bariatric surgery)
- Chronic kidney disease stages 3-4 1
- Patients on medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids)
Safety Parameters
- Upper tolerable limit: 2,000 IU/day for general population 1, though doses up to 10,000 IU/day have been used safely in CKD patients for >1 year 1
- Avoid bolus dosing >500,000 IU annually (associated with increased falls) 2
- Monitor calcium levels only in patients with granulomatous disease, primary hyperparathyroidism, or malignancy 2, 4
- Toxicity is rare below 50,000 IU/day and requires 25(OH)D levels >150 ng/mL 3
Common Pitfall to Avoid
Do NOT use calcitriol or other activated vitamin D analogs (doxercalciferol, paricalcitol) to treat nutritional vitamin D deficiency 1, 7. These are reserved for CKD-mineral bone disease management and carry higher hypercalcemia risk.
Documentation Workaround
If your EMR lacks cholecalciferol:
- Write prescription on paper or use free-text prescribing function
- Specify: "Cholecalciferol 50,000 IU capsules, take one capsule weekly for 8 weeks" (or appropriate regimen)
- Alternatively, document recommendation for OTC purchase with specific brand/dose in visit note
- Request IT add cholecalciferol to formulary for future use